Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856017) titled 'Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for Dynamic Decision-Making' on Sept. 27.

Study Type: Observational

Primary Sponsor: Shanghai Zhongshan Hospital

Condition: Prostate Cancer (Adenocarcinoma) Prostate Cancer (Diagnosis)

Recruitment Status: Recruiting

Date of First Enrollment: July 21, 2026

Target Sample Size: 90

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07856017

Published by HT Digital Content Services with permission from Health Daily Digest....